375853-82-0

Basic information

• Product Name: 1,2,3,6-TETRAHYDROPYRIDINE-4-YL-BORONIC ACID PINACOL ESTER
• Synonyms: 1,2,3,6-TETRAHYDROPYRIDINE-4-YL-BORONIC ACID PINACOL ESTER;1,2,3,6-Tetrahydro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine;1,2,3,6-Tetrahydropyridine-4-boronic acid pinacol ester;Pyridine, 1,2,3,6-tetrahydro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-;4-(4,4,5,5-TetraMethyl-[1,3,2]dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine;1,2,3,6-Tetrahydro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl);(1,2,3,6-TETRAHYDROPYRIDIN-4-YL)BORONIC ACID PINACOL ESTER
• CAS NO: 375853-82-0
• Molecular Formula: C₁₆H₂₈BNO₄
• Molecular Weight: 209.09
• Mol File: 375853-82-0.mol
• Article Data: 74

Chemical Properties

• Boiling Point: 246℃
• Flash Point: 103℃
• Appearance: /
• Density: 0.99
• Vapor Pressure: 0.0278mmHg at 25°C
• Refractive Index: 1.477
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• PKA: 10.66±0.10(Predicted)
• CAS DataBase Reference: 1,2,3,6-TETRAHYDROPYRIDINE-4-YL-BORONIC ACID PINACOL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3,6-TETRAHYDROPYRIDINE-4-YL-BORONIC ACID PINACOL ESTER(375853-82-0)
• EPA Substance Registry System: 1,2,3,6-TETRAHYDROPYRIDINE-4-YL-BORONIC ACID PINACOL ESTER(375853-82-0)

Safety Data

• Hazardous Substances Data: 375853-82-0(Hazardous Substances Data)

Usage

General Description

1,2,3,6-Tetrahydropyridine-4-yl-boronic acid pinacol ester is a chemical compound used in the synthesis of various pharmaceuticals and organic compounds. It is a boronic acid derivative that contains a tetrahydropyridine ring and a pinacol ester group. 1,2,3,6-TETRAHYDROPYRIDINE-4-YL-BORONIC ACID PINACOL ESTER is often used as a reagent in organic chemistry for the Suzuki-Miyaura cross-coupling reaction, where it acts as a boron source in the formation of carbon-carbon bonds. Its unique structure and reactivity make it a valuable tool in the development of new drugs and materials. However, it should be handled with caution as it may pose health and safety risks if not used properly.

InChI:InChI=1/C11H20BNO2/c1-10(2)11(3,4)15-12(14-10)9-5-7-13-8-6-9/h5,13H,6-8H2,1-4H3

Upstream product

• 138647-49-1 4-Trifluoromethanesulfonyloxy-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 73183-34-3 bis(pinacol)diborane 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 10221-56-4 bis(pinacolato)diborane 
• 680192-98-7 deutero-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 76-09-5 2,3-dimethyl-2,3-butane diol 
• 25015-63-8 4,4,5,5-tetramethyl-[1,3,2]-dioxaboralane 
• 159503-91-0 tert-butyl 4-bromo-5,6-dihydropyridine-1(2H)-carboxylate 
• 375853-82-0 tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 24608-52-4 tert-butyl chloroformate 
• 181219-01-2 4-pyridineboronic acid pinacol ester 
• 61676-62-8 2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 1386393-97-0 tert-butyl 4-[(1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonyl)oxy]-3,6-dihydropyridine-1(2H)-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 643746-86-5 tert-butyl 4-(5-{[(benzyloxy)carbonyl]amino}-2,4-difluorophenyl)-3,6-dihydro-1(2H)-pyridinecarboxylate 
• 853643-60-4 tert-butyl 4-(3-bromophenyl)-3,6-dihydropyridine-1(2H)-carboxylate 
• 844501-00-4 tert-butyl 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine-1-carboxylate 
• 437998-30-6 1-t-Butoxycarbonyl-4-(4-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine 
• 474330-33-1 4-[2,5-bis-(2-trifluoromethyl-phenoxymethyl)-phenyl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 474333-13-6 4-[2,6-Bis-(2-trifluoromethyl-phenoxymethyl)-phenyl]-1,2,3,6-tetrahydro-pyridine 
• 606099-75-6 tert-butyl 4-[7-amino-1-(4-nitrophenyl)-1H-pyrazolo[4,3-d]pyrimidine-3-yl]-1,2,3,6-tetrahydro-1-pyridinecarboxylate 
• 864830-05-7 tert-butyl 4-(2-chlorophenyl)-5,6-dihydropyridine-1(2H)-carboxylate 
• 138647-52-6 4-(4-fluorophenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 951774-85-9 C₁₉H₂₅NO₄ 
• 1024028-89-4 4-(3-benzyl-2-cyano-5-methyl-benzofuran-7-yl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 1024028-46-3 4-[2-carbamoyl-1-(3-fluoro-benzyl)-1H-indol-4-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 138647-54-8 4-(2,4-Dichloro-phenyl)-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester 
• 308823-88-3 tert-Butyl 4-[2-(trifluoromethyl)phenyl]-1,2,5,6-tetrahydropyridinecarboxylate 

Relevant articles and documents

COMPOUNDS FOR TARGETED DEGRADATION OF BRD9

BRD9 protein degradation compounds or pharmaceutically acceptable salts thereof are provided for the treatment of disorders mediated by BRD9, including but not limited to abnormal cellular proliferation.

AZAINDOLE DERIVATIVE AND USE THEREOF AS FGFR AND C-MET INHIBITOR

A series of pyrazolopymidine derivatives, and use thereof in the preparation of a medicament for treating disease associated with FGFR and c-Met. The pyrazolopymidine derivative is a compound represented by formula (I), a tautomer, or a pharmaceutically acceptable salt thereof.

MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS

The invention relates to modulators of Embryonic Ectoderm Development (EED) and/or Polycomb Repressive Complex 2 (PRC2) useful in the treatment of disorders and diseases associated with EEC and PRC2, being macrocyclic azolopyridine derivatives and compositions thereof of Formula (I), or a pharmaceutically acceptable salt, prodrug, solvate, hydrate, enantiomer, isomer, or tautomer thereof, wherein X1, X2, X3, A1, A2, Y, R1, R2, R3, and R4 are as described herein.